Effect of exercise training on erythrocyte insulin-like growth factor-I receptor binding in adolescent males

Journal of Pediatric Endocrinology and Metabolism

Volumn 13, Issue 6, 2000, Pages 621-627

  Lee, Caroline ^a   Eliakim, Alon ^a   Brasel, Jo Anne ^a   Cooper, Dan M ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Clinical Research Center   (United States)

Author keywords

Adolescent; Erythrocyte; Exercise; IGF I; Receptor; Training

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDURANCE; ERYTHROCYTE; EXERCISE; GROWTH; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; RECEPTOR UPREGULATION; VOLUNTEER;

EID: 0033937211     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2000.13.6.621     Document Type: Article

References (23)

1. Eliakim A, Barstow TJ, Brasel JA, Ajie H, Lee W-NP, Renslo R, Berman N, Cooper DM. The effect of exercise training on energy expenditure, muscle volume, and maximal oxygen uptake in adolescent females. J Pediatr 1996; 129: 537-543.
2. Eliakim A, Brasel JA, Barstow TJ, Mohan S, Cooper DM. Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males. Med Sci Sport Exercise 1998; 30: 512-517.
3. Smith AT, Clemmons DR, Underwood LE, Ben-Ezra C, McMurray R. The effect of exercise on plasma somatomedin-C/insulin-like growth factor I concentrations. Metabolism 1987; 36: 533-537.
4. Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM. Physical fitness, endurance training, and the GH-IGF-I system in adolescent females. J Clin Endocrinol Metab 1996; 81: 3986-3992.
5. Eliakim A, Brasel JA, Mohan S, Cooper DM. Increased physical activity and the growth hormone insulin-like growth factor-I axis in adolescent males. Am J PhysiolRegul Integr C 1998; 275: R308-R314.
6. Catanese VM, Grigorescu F, King GL, Kahn CR. The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation. J Clin Endocrinol Metab 1986; 62: 692-699.
7. Polychronakos C, Guyda HJ, Posner BI. Receptors for the insulin-like growth factors on human erythrocytes. J Clin Endocrinol Metab 1983; 57: 436-438.
8. Eshet R, Dux Z, Silbergeld A, Koren R, Klinger B, Laron Z. Erythrocytes from patients with low serum concentrations of IGF-I have an increase in receptor sites for IGF-I. Acta Endocrinol (Copenh) 1991; 125: 354-358.
9. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts CT. Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 1993; 10: 115-120.
10. Mandel S, Moreland E, Nichols V, Hanna C, LaFranchi S. Changes in insulin-like growth factor-I (IGF-I), IGF binding protein-3, growth hormone binding protein, erythrocyte IGF-I receptor, and growth rate during growth hormone therapy. J Clin Endocrinol Metab 1995; 80: 190-194.
11. Moromisato D, Roberts CJ, Brasel JA, Mohan S, Cowles E, King SM, Cooper DM. Erythrocyte insulin-like growth factor-I binding in younger and older males. Clin Endocrinol 1998; 48: 339-345.
12. Munson PJ. A User's Guide to LIGAND: Data analysis and curve-fitting for ligand binding experiments. Bethesda, MD: Division of Computer Research and Technology, NIH, 1992.
13. Munson PJ, Rodbard D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 107: 220-239.
14. Rajaram S, Baylink DJ, Mohan S. Insulin-like growth factor binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 18: 801-831.
15. Mohnike K, Kluba U, Blum WF, Aumann V, Vorwerk P, Mittler U. [Serum concentrations of insulin-like growth factor (IGF)-I and IGF-II and IGF binding protein (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors], [in German]. Klin Padiat 1995; 207: 225-229.
16. Tonshoff B, Blum WF, Wingen AM, Mehls O. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Clin Endocrinol Metab 1995; 80: 2684-2691.
17. Wabitsch M, Blum WF, Muche R, Heinze E, Haug C, Teller W. Insulin-like growth factors and their binding proteins before and after weight loss and their associations with hormonal and metabolic parameters in obese adolescent girls. Int J Obesity 1996; 20: 1073-1080.
18. Adams GR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. In: Holloszy JH, ed. Exercise and Sports Science Reviews. Baltimore, MD: Williams and Wilkins, 1998; 31-60.
19. Willis PE, Chadan SG, Baracos V, Parkhouse WS. Restoration of insulin-like growth factor I action in skeletal muscle of old mice. Am J Physiol 1998; 275: E525-E530.
20. Willis PE, Chadan S, Baracos V, Parkhouse WS. Acute exercise attenuates age-associated resistance to insulin-like growth factor I. Am J Physiol 1997; 272: E397-E404.
21. Taaffe DR, Jin IH, Vu TH, Hoffman AR, Marcus R. Lack of effect of recombinant human growth hormone (GH) on muscle morphology and GH-insulin-like growth factor expression in resistance-trained elderly men. J Clin Endocrinol Metab 1996; 81: 421-425.
22. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT. Molecular biology of the IGF-I receptor. In: Merimee TJ, Laron Z, eds. Growth Hormone, IGF-I and Growth, New Views of Old Concepts. London-Tel Aviv: Freund Publishing House Ltd., 1996; 73-99.
23. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 1995; 270: 20424-20431.